RxDoctor Payments Data

Diane Andresen

Adult Health · Northvale, NJNPI 1649290800

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $39,315 of the $60,400 with a category attached, or 65.1%. Exelixis Inc. accounts for 89.4% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2023 at $20,179 and has fallen 84.7% since, to $3,095 in 2025. Among adult health clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$60,400in general payments, 2019–2025

Across 195 payments — averaging $309.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exelixis Inc.$54K
  • AstraZeneca$4K
  • Astellas Pharma US Inc$654
  • Eisai Inc.$520
  • Johnson & Johnson$305
  • Jazz Pharmaceuticals Inc.$134
  • plus $757 from 18 others

What the payments were for

  • Consulting fees$5001%
  • Speaking & faculty fees$39,31565%
  • Travel & lodging$16,19927%
  • Food & beverage$3,6626%
  • Education$7241%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$60,400 in reported general payments places this provider in the 95th percentile of 1,135 adult health providers in New Jersey.

See all adult health providers in New Jersey

Most prescribed under Part D

DrugClaimsCost to plans & patients
CabometyxCabozantinib S-Malate16$400,577
FotivdaTivozanib Hcl13$393,792
Abiraterone Acetate77$88,511
EliquisApixaban11$9,606
Prednisone117$490
Prochlorperazine Maleate27$389
Oxycodone Hcl19$329
Venlafaxine Hcl ErVenlafaxine Hcl32$237
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen23$209
Levothyroxine Sodium36$192
Acetaminophen-CodeineAcetaminophen With Codeine11$182
Ondansetron Hcl37$157
Potassium Chloride14$106
Lorazepam21$58
Alprazolam16$25

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Exelixis Inc.Cabometyx$53,991$400,57716 claims
PfizerEliquis$102$9,60611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,135 adult health providers in New Jersey.

Other adult health in Northvale

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →